To determine cell-mediated immune mechanisms involved in the resolution of chlamydial genital infection of mice, we utilized an established murine model in which it has been demonstrated that resolution of infection occurs independently of the antibody response. Splenic T lymphocytes were obtained from mice that had previously been immunized with viable elementary bodies of the mouse pneumonitis agent (MoPn), a Chlamydia trachomatis biovar. Antigen-reactive T lymphocytes were maintained and expanded in vitro by frequent restimulation with UV light-inactivated MoPn in the presence of antigen-presenting cells and recombinant interleukin-2 (rIL-2). Flow cytometry indicated that this cell line was at least 92 % positive for the panspecific T-cell marker Thyl.2. Stimulation of the cells in the presence of syngeneic antigen-presenting cells plus MoPn antigen and in the absence of exogenous IL-2 induced the cells to produce IL-2 activity in culture supernatants. Following adoptive transfer, this T-lymphocyte line was effective in inducing resolution of an ongoing MoPn genital infection in congenitally athymic nude mice which otherwise maintain chronic unresolved infections. The line was less efficient in resolving the infection after longer periods in culture. An additional T-lymphocyte line was derived from the spleens of athymic mice that had received the first line and had resolved the infection. These T cells were also capable of inducing resolution of the infection. Lastly, this cell line was treated with specific antibody and complement to delete either CD4+ or CD8+ T lymphocytes in an attempt to enrich for T-cell subpopulations prior to transfer into infected athymic mice. The anti-CD4-treated line was essentially depleted of CD4 cells, while the anti-CD8-treated line was only partially enriched for CD4 cells, with a large proportion of CD8 cells still present. Nude mice that received either of the treated T-cell lines or the parental cell line were capable of resolving the infection, although the line with increased numbers of CD4 cells was more efficient than either the parental line or the CD8 line.
The relative roles of the antibody and cell-mediated immune (CMI) responses in chlamydial genital infection of humans remain unclear. Some evidence has been provided that implicates a role for local antibody in reducing the amount of Chlamydia trachomatis isolated from the genital tracts of infected females (3) . However, while CMI responses have been measured following infection in humans (20, 21) , the exact function of T cells is difficult to discern. Therefore, the immunologic parameters critical to resolution of and resistance to chlamydial genital infection have been studied in animal models. In female guinea pigs infected genitally with the agent of guinea pig inclusion conjunctivitis, a C. psittaci agent, it has been found that both CMI and antibody responses cooperate to resolve the infection and provide resistance to reinfection (24, 25, 27, 28) .
Another useful model has been that of female mice infected in the genital tract with mouse pneumonitis agent (MoPn), a C. trachomatis biovar (2) . Congenitally athymic nude (nulnu) mice developed chronic genital infections with MoPn which did not resolve during the period of observation, 265 days, in comparison with their heterozygous (nul+) littermates which resolved the infection in approximately 20 days (26) . However, since the nulnu mice did not develop significant antibody responses compared with the nul+ mice, it could not be discerned whether the unresolved infection was due to insufficient CMI responses or a lack of antibody-mediated mechanisms. Nonetheless, in a later study, it was found that B-cell-deficient mice are capable of resolving the infection and are immune to a challenge * Corresponding author.
infection (23) . Thus, in this model, T cells eliciting CMI and not antibody responses are essential to resolution of the infection and provision of immunity to reinfection. Additionally, it has been found that despite in vivo depletion of either CD4+ or CD8+ T cells, animals are capable of resolving the infection (22) . A common mechanism of these two T-cell subpopulations was implicated when animals treated with monoclonal antibody to murine gamma interferon (IFN--y) sustained a significantly prolonged infection (22a) .
Preliminary to the present study, data indicated that adoptive transfer of either immune or normal nul+ whole spleen cells, as well as B-cell-enriched and T-cell-enriched populations from immune nul+ mice, was capable of resolving the infection in nulnu mice (23a). These results provide an opportunity to utilize adoptive transfer of cultured T-cell lines to further dissect the contribution of CMI mechanisms to resolution of this infection. Here we report the production and partial characterization of MoPn-specific T-cell lines from nul+ mice that are capable of resolving MoPn genital infections in nulnu mice.
MATERIALS AND METHODS
Animals. Five-to six-week-old female nulnu and nul+ mice on a BALB/c background were obtained from Harlan Sprague-Dawley, Inc., Indianapolis, Ind. All mice were maintained in Plexiglas isolators under pathogen-free conditions and fed sterile food and water ad libitum in an environmentally controlled room with a cycle of 12 7 days, mice were sacrificed and used to prepare immune T-lymphocyte cultures as described below. This immunization regimen often resulted in marked splenomegaly.
Preparation of splenic T cells for culture. Mice were sacrificed by cervical dislocation while they were under sodium pentobarbital anesthesia. Spleens were aseptically removed and teased into single-cell suspensions in cold RPMI 1640. Erythrocytes were lysed following centrifugation at 400 x g and suspension in 0.17 M Tris-buffered NH4Cl (pH 7.3). After centrifugation through fetal bovine serum and extensive washing in cold RPMI 1640, the cell suspension was enriched for T cells by passage and elution over a nylon wool column. The effluent cells were washed and suspended in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 0.05 mM 2-mercaptoethanol, 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer, 0.1 mM nonessential amino acids, 1.0 mM sodium pyruvate, 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml; henceforth referred to as lymphocyte culture medium (LCM).
Preparation of antigen-presenting cells (APCs). Normal, nonimmune nul+ mice were sacrificed as described above. Spleens were aseptically removed and teased into single-cell suspensions in cold RPMI 1640. The cells were then washed twice by centrifugation through cold RPMI 1640, gamma irradiated (2,200 rads), washed again, and suspended in LCM. For T-lymphocyte cultures, these cells were incubated for 3 h with 5 ,g of Renografin-gradient-purified, UV light-inactivated, HeLa cell-grown MoPn (Ag) per ml prior to addition of T cells.
Initiation and propagation of MoPn-specific T-lymphocyte lines. For the initial in vitro stimulation period, pooled T-enriched spleen cells were suspended to 2 x 106 cells per ml in LCM. Five milliliters (107 cells) was added to each well of six-well culture plates also containing 107 APCs plus Ag in 5 ml of LCM (1:1 ratio of T cells to APCs). Cultures were then incubated at 37°C in a humidified atmosphere containing 5% CO2. After 18 to 24 h, recombinant murine interleukin-2 (rIL-2; Genzyme Corp., Boston, Mass.) was added at a concentration of 20 U/ml. After an additional 72 to 96 h in culture, the cells were harvested and viable lymphocytes were isolated by recovery at the interface of a FicollHypaque gradient (density, 1.0875). For secondary stimulation, the cells were extensively washed and suspended to 106 cells per ml in LCM. A 2.5-ml volume of this suspension was added to an equal volume of LCM containing 107 fresh APCs plus Ag in each well of six-well culture plates (1:4 ratio of T cells to APCs), and rIL-2 was added at 20 U/ml. The secondary culture was then incubated as described above for 72 h. At the end of this incubation period, the cultures were fed by gentle addition of 5 from anesthetized mice by puncture of the retroorbital venous plexus. Vaginal secretions were obtained by flushing the vaginal vault with phosphate-buffered saline as described elsewhere (23) . Serum IgG and secretion IgA responses were measured by an enzyme-linked immunoadsorbant assay (ELISA) as described elsewhere (10). Assessment of DTH. Delayed-type hypersensitivity (DTH) responses were assessed as previously described (1) . Briefly, hind footpads were injected with 5 p,g of Ag in 0.05 ml of phosphate-buffered saline. Footpad thickness was measured just prior to injection and at 24 h postinjection. As a control for nonspecific inflammation, the contralateral footpads of some mice were injected with phosphate-buffered saline only. The minimum increase in footpad thickness for a positive DTH response was considered to be 0.3 mm by previously described criteria (1). While not performed in the current study, no significant reactions have ever been noted when infected mice were tested with host cell control (HeLa) antigen.
T-lymphoblast transformation assays. Both antigen-specific and mitogen-induced lymphoblast transformation assays for nylon wool-enriched splenic T cells were performed as previously described (23 (pan-T cell), L3T4 (helper-inducer T cell), and Lyt2.2 (suppressor-cytotoxic T cell). The MMT2 cell line most closely resembled the staining pattern of noncultured T-enriched spleen cells from a normal nul+ mouse. The MMT2.1 cell line was derived from nulnu mice that had received an adoptive transfer from the MMT2 line and subsequently resolved the infection. This T-cell line was predominantly Lyt2.2+ (92%), but histograms revealed a distinct portion of cells that stained positive for the L3T4 surface marker. An attempt was made to enrich this line further for Lyt2.2+ cells by treatment with antibody to the L3T4 surface marker plus C. Simultaneously, another portion of the MMT2.1 cell line was treated with anti-Lyt2.2 plus C. While the treatments with anti-Lyt2.2 plus C did not achieve substantial depletion of the targeted cells (probably because of the predominance of Lyt2.2+ cells), a distinct population of L3T4+ cells was present in the MMT2.1.4 cell line but was not readily apparent in histograms of the MMT2.1.2 line (data not shown). Additionally, these two cell lines showed significantly different characteristics in vitro and in vivo in recipients of adoptive transfers (results discussed below).
Responses of T-lymphocyte lines to antigen stimulation. The responses of T-cell lines to antigen are shown in Table 3 . Both the MMT2 and MMT2.1 cell lines showed significant proliferative responses to MoPn above that of APCs in the absence of MoPn (P < 0.0001; two-tailed t test). Also, both cell lines possessed IL-2 activity in culture supematants in response to MoPn antigen plus APC and in the absence of exogenous IL-2. However, the MMT2 line possessed a significantly higher amount of IL-2 activity in culture supernatants (P < 0.0001; two-tailed t test). The IL-2 activity produced by the MM2.1.4 cell line, which possessed a distinct population of L3T4+ cells, was (Fig. 1) , although 9 of 10 animals resolved the infection with the former, compared with 6 of 10 with the latter, by day 50. However, the infection was significantly shorter in mice that received the MMT2.1.4 (L3T4+ Lyt2.2+) line than in recipients of either the MMT2.1.2 (L3T4-Lyt2.2+) or MMT2.1 line (P < 0.02; Wilcoxon signed-ranks test). Also, nine of nine animals that received the MMT2.1.4 line resolved the infection.
When immunological parameters were assessed, it was found that, unlike previous experiments, the DTH response was not present in all of the animals that had resolved the infection (Table 4) compared by a two-factor (T-cell line and days) analysis of variance with repeated measures on one variable (days) (P < 0.0001; Fig. 2 ). Responses of infected and resolved animals to ConA were consistently positive in each group.
DISCUSSION
In this study, we demonstrated that T-lymphocyte lines specific for the mouse biovar of C. trachomatis, MoPn, could be established and maintained in culture but still retain the ability to transfer immunity to immunologically naive recipients. Two related lines were developed. The original line was derived from spleen cells of nul+ mice that had been immunized intravenously with viable MoPn elementary bodies. To select for a line which was more enriched for protective T cells, splenic T cells from nulnu mice that had received the original line and subsequently resolved the infection were also cultured. These T-cell lines were each greater than 90% positive for panspecific T-cell surface marker Thyl.2. The primary line (MMT2) was 64% L3T4+ and 24% Lyt2.2+, whereas the line derived from nulnu recipients of the primary line was 9% L3T4+ and 92% Lyt2.2+ (MMT2.1). Both lines were protective despite the differences in subpopulation proportions. IL-2 activity was greatest in the line containing higher percentages of L3T4+ cells, as one might expect, since Lyt2+ cells do not elaborate IL-2. Additionally, preliminary results have indicated that both of these cell lines produce IFN--y in response to stimulation with antigen plus APCs.
Also of interest is the observation that T-cell lines derived from the spleen were capable of resolving an infection in the genital tract. Normally, one would not anticipate that spleen cells could routinely home to a mucosal tissue, but it is possible that the cells, while circulating, localized in the genital tract because of the presence of chlamydial antigen and did not require specific receptors for mucosal tissue.
It has been previously reported that long-term-cultured T cells display aberrant homing and functional characteristics (7). In our study, an interesting observation was that T cells in culture for shorter periods were more efficient in resolving the infection after adoptive transfer. This could possibly indicate that homing to the site of the infection, while not necessary, expedites resolution of the infection. Alternatively, the transferred cells or their progeny may have been able to regain at least part of their functional characteristics when returned to an in vivo environment.
Following adoptive transfer into nulnu mice, many of the 104r-i ;- (1, 22, 23) . While it has been observed elsewhere that nulnu mice possess some of the early components of the DTH response (9), the response is immature and is not present at 24 h into the assay, the time when our measurements were reported.
MoPn-specific T-lymphoblast responses were also noted in the majority of adoptive-transfer recipients of these two T-cell lines. These responses closely mirrored the DTH responses in that mice that developed significant DTH reactions often possessed significant antigen-specific T-lymphoblast responses. Lastly, in most recipients, transfer of these T-cell lines also induced production of IgG antibody titers in serum that were markedly higher than the low and intermittent titers previously reported for unaltered MoPninfected nulnu mice (26 We also observed production of antigen-specific T-lymphoblast transformation in many of the nulnu mice that resolved the infection. As with the DTH reactions, these responses were conspicuously absent in other mice that resolved the infection and were present in several of those that did not. Therefore, it is also difficult to associate this type of T-cell reactivity with resolution of the infection. Interestingly, a vigorous response of T-enriched spleen cells to the T-cell mitogen ConA was observed in all nulnu recipients in each experiment, indicating universal reconstitution with T cells. Although other reports indicate that some immature T cells are present in nulnu mice of this age, these mice do not normally respond to mitogen stimulation by proliferation (13) . It is certainly possible that different clones from the lines became established in different mice, some having protective capability but not the ability to elicit a detectable DTH response, while others could produce a DTH response but no protection.
As with the DTH reactions and antigen blast transformation, it is difficult to draw conclusions relating antibody production with resolution of the infection in these experiments, since a broad range of antibody titers was found in animals that resolved the infection, as well as in those that did not. However, while antibody may play a participatory role in resolution of this infection, previous reports have indicated that antibody is not essential to resolution of the infection (23) . Also, nulnu mice that received a passive antibody transfer were unable to resolve the infection (23a). Therefore, production of antibody in these experiments indicates that resident B cells receive assistance from T cells that are otherwise not present or functional.
These results support our previous findings that mice depleted of either L3T4+ or Lyt2.2+ T cells are capable of resolving MoPn genital infection (22) . Since IFN-y production is common to both L3T4+ and Lyt2.2+ T cells (11, 12, 17) , it is possible that this is a key factor in resolution of the infection. Indeed, others have also shown that IFN--y can inhibit chlamydial replication in vitro (5, 29) . Additionally, IFN--y has been implicated in protection of mice from lethal MoPn lung infections (4, 30) . Lastly, there were several nulnu recipients of the L3T4-Lyt2.2+ MMT2.1.2 T-cell line that had little or no indication of helper-inducer T-cell activity, as assessed by low DTH activity, antibody responses, and T-lymphoblast transformation responses. However, these mice still resolved the infection. This observation could implicate cytotoxic T-cell activity against MoPn-infected cells in these animals, although cell-mediated cytotoxicity of Chlamydia-infected cells has not been convincingly established (14, 18, 19) .
Nevertheless, the primary importance of successful propagation and adoptive transfer of cultured antigen-specific T-cell lines that induce resolution of MoPn genital infection lies in the possibility of deriving clones from these lines. In future studies, successful propagation and adoptive transfer of cloned MoPn-specific T-cell lines should allow for more clear-cut dissection of the mechanisms by which these cells mediate resolution of this infection, as well as identification of chlamydial antigens capable of eliciting protective cellmediated immune responses in this model.
